Penn Medicine Abramson Cancer Center


 

Penn Medicine HemOnc Panel Discussion: When to Treat Patients With T-Cells, CAR-T as a New SoC for Relapsed Myeloma, CLL Developments, MRD Negativity & Transplant

34 views
May 4, 2022
Comments 0
Login to view comments. Click here to Login